SL
MEDS

Sentinus LLC’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Sentinus LLC’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96K Buy
+406
New +$5.57K ﹤0.01% 596

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sentinus LLC's MEDS Position: Q1 2026 in Review

Sentinus LLC opened a new position in DataMeds AI, Inc. Common Stock (MEDS) in Q1 2026: 406 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #596 among its holdings.

13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

  • Sentinus LLC held 406 shares of DataMeds AI, Inc. Common Stock worth $1.96K as of Q1 2026.
  • DataMeds AI, Inc. Common Stock was a new Sentinus LLC position in Q1 2026.
  • DataMeds AI, Inc. Common Stock made up ﹤0.01% of Sentinus LLC's portfolio in Q1 2026, its #596 holding.
  • 13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.